Streetbeat News

Stock Prices

DXCM

A significant bearish stance has been taken on DexCom (NASDAQ:DXCM) by a large investor, as observed from publicly available options history. The overall sentiment of these big-money traders is split between 18% bullish and 81% bearish. The whales have been targeting a price range from $85.0 to $95.0 for DexCom over the last 3 months. UBS and Raymond James have maintained their Buy and Strong Buy ratings on DexCom, respectively.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 2:01 pm

AMZN

A significant investor has taken a bearish stance on Amazon.com (NASDAQ:AMZN), with 70% of the spotted trades being bearish. The whales have been targeting a price range from $120.0 to $140.0 for Amazon.com over the last 3 months. The price of AMZN is currently down -1.86% at $123.64. Several experts have downgraded their actions on Amazon.com with price targets ranging from $160 to $180.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 2:01 pm

GCT

GigaCloud Technology's stock price is falling following a short report issued by Culper Research.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 2:01 pm

APLE

Over the past 3 months, 5 analysts have published their opinion on Apple Hospitality REIT (NYSE:APLE) stock. The average price target is $18.6, representing a 2.11% decrease from the previous average price target of $19.00. The ratings are predominantly bullish.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 2:01 pm

NEP

Over the past 3 months, 5 analysts have published their opinion on NextEra Energy Partners (NYSE:NEP) stock. The average price target is $50.4, implying an upside from the current price of $33.7701. This average has decreased by 35.38% from the previous average price target of $78.00.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 2:00 pm

CERE

Over the past 3 months, 5 analysts have published their opinion on Cerevel Therapeutics Hldg (NASDAQ:CERE) stock. The average price target is $34.4, implying an upside from the current price of $21.88. This average has decreased by 11.79% from the previous average price target of $39.00.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 2:00 pm

KRTX

Over the past three months, nine analysts have published their opinions on Karuna Therapeutics (NASDAQ:KRTX) stock. The average price target is $261.22, representing a 5.61% decrease from the previous average price target of $276.75. The majority of the ratings are bullish.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 2:00 pm

OSK

Analysts have provided various ratings for Oshkosh (NYSE:OSK) within the last quarter, with a total of 3 bullish, 5 somewhat bullish, and 4 indifferent ratings. The average 12-month price target for Oshkosh is $112.25, which has increased by 16.66% over the past month.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 2:00 pm

EL

Estee Lauder Cos (NYSE:EL) has outperformed the market over the past 20 years by 3.51% on an annualized basis, producing an average annual return of 10.79%. If an investor had bought $1000 of EL stock 20 years ago, it would be worth $7,912.09 today.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 2:00 pm

CRM

Salesforce (NYSE:CRM) has outperformed the market over the past 10 years by 4.54% on an annualized basis, producing an average annual return of 14.19%. If an investor had bought $100 of CRM stock 10 years ago, it would be worth $380.77 today.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 2:00 pm